Perrigo Company plc
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$12.2M
Doctors Paid
60
Transactions
1,026
2024 Total
$60,829
Payment Breakdown by Category
Research$11.3M (92.3%)
Consulting$729,473 (6.0%)
Travel$40,225 (0.3%)
Food & Beverage$10,727 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $11.3M | 870 | 92.3% |
| Consulting Fee | $729,473 | 34 | 6.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $98,755 | 21 | 0.8% |
| Grant | $64,211 | 1 | 0.5% |
| Travel and Lodging | $40,225 | 56 | 0.3% |
| Food and Beverage | $10,727 | 44 | 0.1% |
Payments by Type
Research
$11.3M
870 transactions
General
$943,391
156 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| Bioequivalence study between Perrigo's product and finacea foam | $2.4M | 0 | 222 |
| Bioequivalence study between Perrigo's product and Estrace cream | $1.7M | 0 | 136 |
| Bioequivalence study between Perrigo's product and Epiduo Forte gel | $1.4M | 0 | 120 |
| Bioequivalence study between Perrigo's product and Soolantra cream | $1.3M | 0 | 136 |
| Bioequivalence study between Perrigo's product and Epiduo Forte Gel | $704,548 | 0 | 38 |
| Evaluation of the Reduction in Erythema by RHOFADE Topical Cream, 1 in Patients with Persistent Facial Erythema | $674,613 | 0 | 4 |
| Bioequivalence study between Perrigo's product and AndroDerm 4mg24h patch | $596,100 | 0 | 10 |
| A placebo-controlled safety and efficacy study of vancomycin ophthalmic ointment 1.1 in patients with bacterial conjunsctivitis | $387,884 | 0 | 30 |
| Bioequivalence study between Perrigo's product and Azopt ophthalmic Suspension | $366,005 | 0 | 51 |
| Bioequivalence study | $359,787 | 0 | 27 |
| A study to measure pediatric growth using Perrigo's infant nutrition | $301,610 | 0 | 18 |
| Bioequivalence study between Perrigo's product and Ultravate lotion | $270,700 | 0 | 4 |
| Bioequivalence study between Perrigo's product and Narcan nasal spray | $201,100 | 0 | 7 |
| Bioequivalence study between Perrigo's product and Imitrex nasal spray | $189,698 | 0 | 2 |
| Pediatric Growth | $134,662 | 0 | 15 |
| Bioequivalence study between Perrigo's product and AndroGel 1.62 gel | $118,697 | 0 | 2 |
| Bioequivalence study between Perrigo's product and Oneston gel | $75,015 | 0 | 3 |
| A study to assess reactivity of cows milk allergic CMA subjects to a Perrigo infant nutrition product and Nutramigen | $60,351 | 0 | 35 |
| 12025303 | $58,842 | 0 | 1 |
| Bioequivalence study between Perrigo's product and Zovirax cream | $27,522 | 0 | 3 |
| Bioequivalence study between Perrigo's product and mupirocin calcium cream | $11,750 | 0 | 4 |
| A Multi-Center, Double-Blind, Randomized Vehicle-Controlled, Parallel- Group Study to Compare Perrigo UK FINCOs Acyclovir Cream, 5 with ZOVIRAX | $8,000 | 0 | 1 |
| Efficacy & Consumer Perception | $5,000 | 0 | 1 |
Payments by Medical Specialty
| Specialty | Total Paid | Doctors | Avg/Doctor |
|---|---|---|---|
| Emergency Medical Services | $551,058 | 1 | $551,058 |
| Pediatrics | $66,102 | 3 | $22,034 |
| Obstetrics & Gynecology | $36,874 | 3 | $12,291 |
| Pediatric Allergy/Immunology | $34,082 | 2 | $17,041 |
| Addiction Medicine | $26,537 | 1 | $26,537 |
| Infectious Disease | $22,350 | 4 | $5,588 |
| Internal Medicine | $20,298 | 1 | $20,298 |
| Ophthalmology | $19,898 | 12 | $1,658 |
| Emergency Medicine | $14,691 | 2 | $7,345 |
| Dermatology | $13,055 | 6 | $2,176 |
| Medical | $12,350 | 1 | $12,350 |
| Gastroenterology | $12,300 | 2 | $6,150 |
| Pediatric Dentistry | $10,000 | 1 | $10,000 |
| Allergy & Immunology | $7,664 | 1 | $7,664 |
| Allergy | $5,093 | 2 | $2,546 |
| Family Medicine | $4,325 | 3 | $1,442 |
| Geriatric Medicine | $2,538 | 1 | $2,538 |
| Pediatric Gastroenterology | $2,250 | 1 | $2,250 |
| Retina Specialist | $2,225 | 1 | $2,225 |
| General Practice | $2,002 | 2 | $1,001 |
| Rheumatology | $1,853 | 1 | $1,853 |
| Pulmonary Disease | $1,851 | 1 | $1,851 |
| Reproductive Endocrinology | $1,529 | 1 | $1,529 |
| MOHS-Micrographic Surgery | $1,278 | 1 | $1,278 |
| Specialist | $1,273 | 1 | $1,273 |
| Women's Health | $555.00 | 1 | $555.00 |
| Student in an Organized Health Care Education/Training Program | $300.00 | 1 | $300.00 |
Top Paid Doctors — Page 3
| Doctor | Specialty | Location | Total | 2017 |
|---|---|---|---|---|
| Leona Chen, Md, MD | Ophthalmology | New York, NY | $975.00 | $0 |
| Dr. Eddie Armas, Md, MD | General Practice | South Miami, FL | $906.53 | $0 |
| Marjorie Searcy, Arnp, ARNP | Women's Health | Phoenix, AZ | $555.00 | $0 |
| Dr. Gary Heller, D.o, D.O | Dermatology | Pinellas Park, FL | $488.09 | $0 |
| Dr. Marguerite Mcdonald, M.d, M.D | Ophthalmology | Oceanside, NY | $487.50 | $0 |
| John Gnann, Md, MD | Infectious Disease | Charleston, SC | $450.00 | $0 |
| Dr. Erica Montes, Md, MD | Student in an Organized Health Care Education/Training Program | Scottsdale, AZ | $300.00 | $0 |
| David Koelle | Infectious Disease | Seattle, WA | $300.00 | $0 |
| Steven Solomon, M.d, M.D | Infectious Disease | Decatur, GA | $300.00 | $0 |
| Dr. Charles Ellis, Md, MD | Dermatology | Ann Arbor, MI | $101.73 | $0 |
Ad
Top Products
- Estradiol Vaginal Cream USP, 0.01% $1.7M
- Brinzolamide Ophthalmic Suspension 1% $288,637
Associated Products (8)
- Estradiol Vaginal Cream USP, 0.01% $1.7M
- Brinzolamide Ophthalmic Suspension 1% $288,637
- Testosterone Gel, 1.62% $118,697
- Selenium Sulfide Lotion 2.5% $89,663
- Betamethasone Dipropionate Lotion 0.05% $77,610
- Mupirocin Cream USP, 2% $71,150
- Desonide Cream 0.05% $61,186
- Betamethasone Dipropionate $58,842
Payment Categories
- Food & Beverage $10,727
- Consulting $729,473
- Travel & Lodging $40,225
- Research $11.3M
About Perrigo Company plc
Perrigo Company plc has made $12.2M in payments to 60 healthcare providers, recorded across 1,026 transactions in the CMS Open Payments database. In 2024, the company paid $60,829. The top product by payment volume is Estradiol Vaginal Cream USP, 0.01% ($1.7M).
Payments were distributed across 27 medical specialties. The top specialty by payment amount is Emergency Medical Services ($551,058 to 1 doctors).
Payment categories include: Food & Beverage ($10,727), Consulting ($729,473), Research ($11.3M), Travel & Lodging ($40,225).
Perrigo Company plc is associated with 8 products in the CMS Open Payments database, including Estradiol Vaginal Cream USP, 0.01%, Brinzolamide Ophthalmic Suspension 1%, and Testosterone Gel, 1.62%.